眼科黏彈裝置市場規模、佔有率、成長分析（按產品類型、按應用、按最終用戶、按地區）- 產業預測，2025 年至 2032 年

預計 2023 年全球眼科黏彈劑市場價值將達到 105 億美元，並從 2024 年的 117.2 億美元成長到 2032 年的 281.9 億美元，預測期內（2025-2032 年）的複合年成長率為 11.6%。

隨著白內障、青光眼和老齡化黃斑部病變等眼科疾病的發生率不斷上升，眼科黏彈劑 (OVD) 市場正在強勁成長。對微創眼科手術的需求不斷成長以及黏彈性材料配方的進步是這一市場擴張的驅動力。 OVD 在手術過程中發揮著至關重要的作用，它提供空間、穩定組織並防止視力喪失。由於全球眼科手術激增、醫療保健可及性的改善以及人們對眼科疾病的認知不斷提高，預計該市場將會成長。此外，黏度自適應 OVD 擴大被採用，特別是在複雜的眼科手術中，因為它們可以有效地消除對多個注射器的需求。總之，這些因素正在推動該產業向前發展。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

眼科黏彈劑裝置市場規模（依產品類型及複合年成長率）（2025-2032）

• 市場概覽
• 疏水性
• 親水性
• 組合

眼科黏彈劑裝置市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 黏性眼科黏彈劑
• 可分散眼科黏彈劑

眼科黏彈劑裝置市場規模：依組件和複合年成長率（2025-2032）

• 市場概覽
• 透明質酸鈉
• 硫酸軟骨素
• 羥丙基甲基纖維素

眼科黏彈裝置市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 白內障手術
• 角膜手術
• 青光眼手術
• 屈光矯正手術

眼科黏彈裝置市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 門診手術中心
• 眼科診所

眼科黏彈劑市場規模（按劑型類型和複合年成長率）（2025-2032）

• 市場概覽
• 一次性的
• 多用途

眼科黏彈裝置市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

    主要企業簡介

    • 愛爾康（瑞士）
    • 博士倫（博士倫醫療）（美國）
    • 卡爾蔡司醫療公司（德國）
    • 強生視力保健公司（美國）
    • 雷納人工水晶體有限公司（英國）
    • Bohus BIoTech AB（瑞典）
    • Lifecore Biomedical LLC（美國）
    • 豪雅株式會社（日本）
    • 參天製藥株式會社（日本）
    • Croma-Pharma GmbH（奧地利）
    • Eyekon Medical Inc.（美國）
    • RUMEX國際公司（美國）
    • Ziemer Ophthalmic Systems AG（瑞士）
    • Ophtechnics Unlimited（印度）
    • 昊海生物科技（中國）
    • Amring Pharmaceutical Inc.（美國）
    • Truviz眼科公司（美國）
    • Cima Technology Inc.（美國）

結論和建議

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 10.5 billion in 2023 and is poised to grow from USD 11.72 billion in 2024 to USD 28.19 billion by 2032, growing at a CAGR of 11.6% during the forecast period (2025-2032).

The ophthalmic viscoelastic devices (OVDs) market is experiencing robust growth fueled by the rising prevalence of eye disorders, including cataracts, glaucoma, and age-related macular degeneration. Increasing demand for minimally invasive eye surgeries, along with advancements in viscoelastic material formulations, is driving this expansion. OVDs play a vital role during surgeries by preserving space, stabilizing tissues, and preventing vision loss. With a surge in ophthalmic surgeries worldwide, improved access to care, and heightened awareness of ocular disorders, the market is set to thrive. Furthermore, the adoption of viscoadaptive OVDs is gaining traction, particularly in complex ocular procedures, due to their efficiency in reducing the need for multiple syringes. Overall, these factors are collectively propelling the industry forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ophthalmic Viscoelastic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is being significantly propelled by the rising occurrence of various eye disorders, including cataracts, glaucoma, and age-related macular degeneration, which correlate closely with an aging demographic and changing lifestyle choices. These conditions frequently require surgical treatments, underscoring the importance of ophthalmic viscoelastic devices that safeguard the eye's sensitive tissues, preserve surgical space, and enhance the overall surgical experience. As the patient population seeking such interventions increases, there is a correspondingly higher demand for superior viscoelastic products, thereby driving the market's growth and presenting opportunities for innovation in this critical healthcare segment.

Restraints in the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market faces a notable challenge due to the high costs associated with advanced devices that utilize innovative materials and improved biocompatibility. This elevated pricing poses a substantial obstacle for hospitals and clinics, particularly in emerging markets or areas with constrained healthcare budgets. As a result, patients in low and middle-income countries often encounter difficulties in accessing these premium products, primarily due to affordability concerns. Consequently, this situation restricts the overall market penetration of advanced ophthalmic viscoelastic devices in these regions, limiting their widespread adoption and use in vital eye care procedures.

Market Trends of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is witnessing a significant trend towards the integration of artificial intelligence (AI) and digital technologies within surgical workflows. This innovation is enhancing preoperative planning, intraoperative guidance, and postoperative care, particularly in the application of viscoelastic devices. As AI-driven imaging and surgical assistance become more sophisticated, they offer improved precision and reduced risks during procedures, which in turn leads to better surgical outcomes. This synergy is driving increased adoption rates of viscoelastic devices that are compatible with advanced AI systems, positioning the market for robust growth as these technologies become standard in ophthalmic surgery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ophthalmic Viscoelastic Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Hydrophobic
• Hydrophilic
• Combination

Global Ophthalmic Viscoelastic Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Cohesive Ophthalmic Viscoelastic
• Dispersive Ophthalmic Viscoelastic

Global Ophthalmic Viscoelastic Devices Market Size by Composition & CAGR (2025-2032)

• Market Overview
• Sodium Hyaluronate
• Chondroitin Sulfate
• Hydroxypropyl Methylcellulose

Global Ophthalmic Viscoelastic Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cataract Surgery
• Corneal Surgery
• Glaucoma Surgery
• Refractive Surgery

Global Ophthalmic Viscoelastic Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics

Global Ophthalmic Viscoelastic Devices Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Single-Use
• Multi-Use

Global Ophthalmic Viscoelastic Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • US
  • Canada
• Europe (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Composition, Application, End User, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Composition, Application, End User, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (Bausch Health) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma-Pharma GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyekon Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RUMEX International Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ziemer Ophthalmic Systems AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtechnics Unlimited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haohai Biological Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amring Pharmaceutical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Truviz Ophthalmic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cima Technology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations